ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,633.91
      0.00%
      US Tech 100
      20,116.80
      -0.01%
      Dow Jones
      39,721.36
      0.00%
      Brent Oil
      84.725
      -0.38%
      Bitcoin
      58,732.13
      1.69%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Gemphire Therapeutics Inc (GEMP)

      7. Gemphire Therapeutics Inc (GEMP) News

      GEMP

      Gemphire Therapeutics (GEMP)

      Gemphire Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GEMP
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      12:30PMiHub NewswireFeaturedECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch
      08/01/20174:30PMGlobeNewswire Inc.Gemphire Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:GEMPGemphire Therapeutics Inc
      07/27/20173:35PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
      07/25/20178:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      07/25/20178:00AMGlobeNewswire Inc.Gemphire Enters Into $15 Million Term Loan Agreement With Silicon Valley BankNASDAQ:GEMPGemphire Therapeutics Inc
      06/28/20174:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      06/28/20174:01PMGlobeNewswire Inc.Gemphire Announces Top-Line Data from COBALT-1 Phase 2b Clinical Trial in HoFH PatientsNASDAQ:GEMPGemphire Therapeutics Inc
      06/01/20178:00AMGlobeNewswire Inc.Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare ConferenceNASDAQ:GEMPGemphire Therapeutics Inc
      05/31/20174:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GEMPGemphire Therapeutics Inc
      05/30/20174:26PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
      05/30/20174:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      05/30/20174:01PMGlobeNewswire Inc.Gemphire Therapeutics Announces Departure of Its Chief Executive Officer Mina SoochNASDAQ:GEMPGemphire Therapeutics Inc
      05/24/20174:10PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
      05/24/20174:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      05/10/20174:37PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
      05/10/20174:35PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GEMPGemphire Therapeutics Inc
      05/09/20176:59AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      05/09/20176:00AMGlobeNewswire Inc.Gemphire Announces First Quarter 2017 Financial Results and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
      05/01/20176:00AMGlobeNewswire Inc.Gemphire to Present at ATVB|PVD 2017 Scientific SessionsNASDAQ:GEMPGemphire Therapeutics Inc
      04/21/20176:31AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
      04/21/20176:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GEMPGemphire Therapeutics Inc
      04/13/20175:02PMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:GEMPGemphire Therapeutics Inc
      04/06/20174:11PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GEMPGemphire Therapeutics Inc
      03/29/20174:30PMGlobeNewswire Inc.Gemphire Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:GEMPGemphire Therapeutics Inc
      03/29/20174:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GEMPGemphire Therapeutics Inc
      03/21/20179:17AMGlobeNewswire Inc.Gemphire Therapeutics Announces Presentation at ACC Meeting of Phase 2 Clinical Trial Investigating Effect of Gemcabene on In...NASDAQ:GEMPGemphire Therapeutics Inc
      03/21/20176:06AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:GEMPGemphire Therapeutics Inc
      03/20/20171:12PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GEMPGemphire Therapeutics Inc
      03/16/20173:52PMGlobeNewswire Inc.Gemphire to Present at the Oppenheimer Annual Healthcare Conference and the H.C. Wainwright NASH Investor EventNASDAQ:GEMPGemphire Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GEMP